These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6644885)

  • 1. Ploidy disturbance of normal-appearing bladder mucosa in patients with urothelial cancer: relationship to morphology.
    Farsund T; Laerum OD; Høstmark J
    J Urol; 1983 Dec; 130(6):1076-82. PubMed ID: 6644885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder.
    Norming U; Nyman CR; Tribukait B
    J Urol; 1989 Dec; 142(6):1442-7. PubMed ID: 2585616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between flow cytometric DNA distribution and pathology in human bladder cancer. A report on 69 cases.
    Farsund T; Hoestmark JG; Laerum OD
    Cancer; 1984 Nov; 54(9):1771-7. PubMed ID: 6478413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA aberrations of bladder mucosa in patients with transitional cell carcinomas.
    Høstmark JG; Laerum OD; Farsund T
    Scand J Urol Nephrol; 1984; 18(2):113-20. PubMed ID: 6463594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
    de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
    Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas.
    Murphy WM; Chandler RW; Trafford RM
    J Urol; 1986 Apr; 135(4):694-7. PubMed ID: 3959188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
    Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
    Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
    Yu DS; Hsu CM; Chang SY; Ma CP
    J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy.
    Wijkström H; Gustafson H; Tribukait B
    J Urol; 1984 Nov; 132(5):894-8. PubMed ID: 6492278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
    Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
    Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-cytometric deoxyribonucleic acid analysis of the human bladder cancers with reference to histopathological findings.
    Hamano K; Kinjo M; Kumazawa J
    Eur Urol; 1992; 22(2):153-7. PubMed ID: 1478232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of primary and metastatic bladder cancer.
    Badalament RA; O'Toole RV; Keyhani-Rofagha S; Barkley C; Kenworthy P; Accetta P; Wise H; Perez JF; Drago JR
    J Urol; 1990 May; 143(5):912-5; discussion 915-6. PubMed ID: 2329605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.